NLRP3 Inflammasome in Acute Myocardial Infarction

被引:100
作者
Mauro, Adolfo G. [1 ,2 ]
Bonaventura, Aldo [1 ,3 ]
Mezzaroma, Eleonora [1 ,2 ,4 ]
Quader, Mohammed [1 ,5 ,6 ]
Toldo, Stefano [1 ,2 ,5 ]
机构
[1] Virginia Commonwealth Univ, VCU Pauley Heart Ctr, Box 980281, Richmond, VA 23298 USA
[2] Virginia Commonwealth Univ, Johnson Ctr Crit Care Med Pulm Res, Richmond, VA USA
[3] Univ Genoa, Dept Internal Med, Clin Internal Med 1, Genoa, Italy
[4] Virginia Commonwealth Univ, Pharmacotherapy & Outcomes Sci, Richmond, VA USA
[5] Virginia Commonwealth Univ, Dept Cardiothorac Surg, Richmond, VA USA
[6] Hunter Holmes McGuire Vet Affairs Med Ctr, Richmond, VA USA
关键词
NLRP3; inflammasome; acute myocardial infarction; interleukin-1; beta; interleukin-18; caspase-1; ISCHEMIA-REPERFUSION INJURY; PRESERVES CARDIAC-FUNCTION; IL-1 RECEPTOR ANTAGONIST; FACTOR-KAPPA-B; INTERLEUKIN-1; BLOCKADE; HEART-FAILURE; CELL-DEATH; BLOCKING INTERLEUKIN-1; PRESSURE-OVERLOAD; ACTIVATION;
D O I
10.1097/FJC.0000000000000717
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Acute myocardial infarction (AMI) is associated with the induction of a sterile inflammatory response that leads to further injury. The NACHT, leucine-rich repeat, and pyrin domain-containing protein 3 (NLRP3) inflammasome is a macromolecular structure responsible for the inflammatory response to injury or infection. NLRP3 can sense intracellular danger signals, such as ischemia and extracellular or intracellular alarmins during tissue injury. The NLRP3 inflammasome is primed and triggered by locally released damage-associated molecular patterns and amplifies the inflammatory response and cell death through caspase-1 activation. Here, we examine the scientific evidence supporting a role for NLRP3 in AMI and the available strategies to inhibit the effects of the inflammasome. Our focus is on the beneficial effects seen in experimental models of AMI in preclinical animal models and the initial results of clinical trials.
引用
收藏
页码:175 / 187
页数:13
相关论文
共 165 条
[1]   NADPH Oxidase-Mediated Triggering of Inflammasome Activation in Mouse Podocytes and Glomeruli During Hyperhomocysteinemia [J].
Abais, Justine M. ;
Zhang, Chun ;
Xia, Min ;
Liu, Qinglian ;
Gehr, Todd W. B. ;
Boini, Krishna M. ;
Li, Pin-Lan .
ANTIOXIDANTS & REDOX SIGNALING, 2013, 18 (13) :1537-1548
[2]  
Abbate A., 2015, TRANSL MED, V5, pe133
[3]   Comparative Safety of Interleukin-1 Blockade With Anakinra in Patients With ST-Segment Elevation Acute Myocardial Infarction (from the VCU-ART and VCU-ART2 Pilot Studies) [J].
Abbate, Antonio ;
Kontos, Michael Christopher ;
Abouzaki, Nayef Antar ;
Melchior, Ryan David ;
Thomas, Christopher ;
Van Tassell, Benjamin Wallace ;
Oddi, Claudia ;
Carbone, Salvatore ;
Trankle, Cory Ross ;
Roberts, Charlotte Susan ;
Mueller, George Herman ;
Gambill, Michael Lucas ;
Christopher, Sanah ;
Markley, Roshanak ;
Vetrovec, George Wayne ;
Dinarello, Charles Anthony ;
Biondi-Zoccai, Giuseppe .
AMERICAN JOURNAL OF CARDIOLOGY, 2015, 115 (03) :288-292
[4]   Effects of Interleukin-1 Blockade With Anakinra on Adverse Cardiac "Remodeling and Heart Failure After Acute Myocardial Infarction [from the Virginia Commonwealth. University-Anakinra Remodeling Trial (2) (VCU-ART2) Pilot Study] [J].
Abbate, Antonio ;
Van Tassel, Benjamin Wallace ;
Biondi-Zoccai, Giuseppe ;
Kontos, Michael Christopher ;
Grizzard, John Dallas ;
Spillman, Debra Whittaker ;
Oddi, Claudia ;
Roberts, Charlotte Susan ;
Melchior, Ryan David ;
Mueller, George Herman ;
Abouzaki, Nayef Antar ;
Rengel, Lenore Rosemary ;
Varma, Amit ;
Gambill, Michael Lucas ;
Falcao, Raquel Appa ;
Voelkel, Norbert Felix ;
Dinarello, Charles Anthony ;
Vetrovec, George Wayne .
AMERICAN JOURNAL OF CARDIOLOGY, 2013, 111 (10) :1394-1400
[5]  
Abbate A, 2012, BIODRUGS, V26, P217, DOI 10.2165/11631570-000000000-00000
[6]   Alterations in the Interleukin-1/Interleukin-1 Receptor Antagonist Balance Modulate Cardiac Remodeling following Myocardial Infarction in the Mouse [J].
Abbate, Antonio ;
Salloum, Fadi N. ;
Van Tassell, Benjamin W. ;
Vecile, Elena ;
Toldo, Stefano ;
Seropian, Ignacio ;
Mezzaroma, Eleonora ;
Dobrina, Aldo .
PLOS ONE, 2011, 6 (11)
[7]   Interleukin-1β modulation using a genetically engineered antibody prevents adverse cardiac remodelling following acute myocardial infarction in the mouse [J].
Abbate, Antonio ;
Van Tassell, Benjamin W. ;
Seropian, Ignacio M. ;
Toldo, Stefano ;
Robati, Roshanak ;
Varma, Amit ;
Salloum, Fadi N. ;
Smithson, Lisa ;
Dinarello, Charles A. .
EUROPEAN JOURNAL OF HEART FAILURE, 2010, 12 (04) :319-322
[8]   Interleukin-1 Blockade With Anakinra to Prevent Adverse Cardiac Remodeling After Acute Myocardial Infarction (Virginia Commonwealth University Anakinra Remodeling Trial [VCU-ART] Pilot Study) [J].
Abbate, Antonio ;
Kontos, Michael C. ;
Grizzard, John D. ;
Biondi-Zoccai, Giuseppe G. L. ;
Van Tassell, Benjamin W. ;
Robati, Roshanak ;
Roach, Lenore M. ;
Arena, Ross A. ;
Roberts, Charlotte S. ;
Varma, Amit ;
Gelwix, Christopher C. ;
Salloum, Fadi N. ;
Hastillo, Andrea ;
Dinarello, Charles A. ;
Vetrovec, George W. .
AMERICAN JOURNAL OF CARDIOLOGY, 2010, 105 (10) :1371-1377
[9]   Interest of colchicine in the treatment of acute myocardial infarct responsible for heart failure in a mouse model [J].
Akodad, Mariama ;
Fauconnier, Jeremy ;
Sicard, Pierre ;
Huet, Fabien ;
Blandel, Florence ;
Bourret, Annick ;
Barbara, Pascal de Santa ;
Aguilhon, Sylvain ;
LeGall, Marion ;
Hugon, Gerald ;
Lacampagne, Alain ;
Roubille, Francois .
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2017, 240 :347-353
[10]  
Al Z., 2019, J CARDIOVASC PHARM